APA (7th ed.) Citation

CL, H., MJ, Z., M, A., R, R., NS, M., MMA, M., . . . C, C. (2025). Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Transplantation and cellular therapy, 31(3), 174.e1-174.e12. https://doi.org/10.1016/j.jtct.2024.12.021

Chicago Style (17th ed.) Citation

CL, Hickey, et al. "Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis." Transplantation and Cellular Therapy 31, no. 3 (2025): 174.e1-174.e12. https://doi.org/10.1016/j.jtct.2024.12.021.

MLA (9th ed.) Citation

CL, Hickey, et al. "Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis." Transplantation and Cellular Therapy, vol. 31, no. 3, 2025, pp. 174.e1-174.e12, https://doi.org/10.1016/j.jtct.2024.12.021.